Skip to main content
TipRanks
Go Ultimate75% OFF

Swedish Orphan Biovitrum AB (BIOVF) Stock Statistics & Valuation Metrics

1 Followers

Total Valuation

Swedish Orphan Biovitrum AB has a market cap or net worth of $16.08B. The enterprise value is $169.97B.

Market Cap
$16.08B
Enterprise Value
$169.97B

Share Statistics

Swedish Orphan Biovitrum AB has 357,636,500 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
357,636,500
Owned by Insiders
―
Owned by Institutions
11.35%

Financial Efficiency

Swedish Orphan Biovitrum AB’s return on equity (ROE) is 0.01 and return on invested capital (ROIC) is 14.02%.

Return on Equity (ROE)
0.01
Return on Assets (ROA)
0.01
Return on Invested Capital (ROIC)
14.02%
Return on Capital Employed (ROCE)
0.16
Revenue Per Employee
12.79M
Profits Per Employee
216.58K
Employee Count
2,207
Asset Turnover
0.42
Inventory Turnover
3.10

Valuation Ratios

The current PE Ratio of Swedish Orphan Biovitrum AB is 24.45. Swedish Orphan Biovitrum AB’s PEG ratio is 0.00.

PE Ratio
24.45
PS Ratio
5.09
PB Ratio
3.58
Price to FCF
22.35
Price to Operating Cash Flow
20.63
PEG Ratio
0.00

Income Statement

In the last 12 months, Swedish Orphan Biovitrum AB had revenue of 28.24B and earned 478.00M in profits. Earnings per share was 1.39.

Revenue
28.24B
Gross Profit
12.32B
Operating Income
8.05B
Pretax Income
34.00M
Net Income
478.00M
EBITDA
10.96B
Earnings Per Share (EPS)
1.39

Cash Flow

In the last 12 months, operating cash flow was 7.89B and capital expenditures -604.00M, giving a free cash flow of 7.28B billion.

Operating Cash Flow
7.89B
Free Cash Flow
7.28B
Free Cash Flow per Share
20.94

Dividends & Yields

Swedish Orphan Biovitrum AB pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
4.47%
Earnings Yield
4.07%

Stock Price Statistics

Beta
0.71
52-Week Price Change
31.86%
50-Day Moving Average
45.86
200-Day Moving Average
45.88
Relative Strength Index (RSI)
46.38
Average Volume (3m)
2,994

Important Dates

Swedish Orphan Biovitrum AB upcoming earnings date is Feb 04, 2027, Before Open (Not Confirmed).

Last Earnings Date
Oct 27, 2026
Next Earnings Date
Feb 04, 2027
Ex-Dividend Date
―

Financial Position

Swedish Orphan Biovitrum AB as a current ratio of 0.90, with Debt / Equity ratio of 30.48%

Current Ratio
0.90
Quick Ratio
0.59
Debt to Market Cap
0.10
Net Debt to EBITDA
0.95
Interest Coverage Ratio
9.68

Taxes

In the past 12 months, Swedish Orphan Biovitrum AB has paid -442.00M in taxes.

Income Tax
-442.00M
Effective Tax Rate
-13.00

Enterprise Valuation

Swedish Orphan Biovitrum AB EV to EBITDA ratio is 12.99, with an EV/FCF ratio of 24.43.

EV to Sales
5.57
EV to EBITDA
12.99
EV to Free Cash Flow
24.43
EV to Operating Cash Flow
22.56

Balance Sheet

Swedish Orphan Biovitrum AB has $1.00B in cash and marketable securities with $16.15B in debt, giving a net cash position of -$15.15B billion.

Cash & Marketable Securities
$1.00B
Total Debt
$16.15B
Net Cash
-$15.15B
Net Cash Per Share
-$42.36
Tangible Book Value Per Share
-$45.49

Margins

Gross margin is 68.03%, with operating margin of 31.60%, and net profit margin of 20.73%.

Gross Margin
68.03%
Operating Margin
31.60%
Pretax Margin
25.97%
Net Profit Margin
20.73%
EBITDA Margin
42.86%
EBIT Margin
31.59%

Analyst Forecast

The average price target for Swedish Orphan Biovitrum AB is $55.39, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target
$55.39
Price Target Upside
18.59% Upside
Analyst Consensus
Moderate Buy
Analyst Count
5
Revenue Growth Forecast
23.58%
EPS Growth Forecast
―